IL17A and metabolic dysfunction-associated steatotic liver disease: More careful investigation of the biological and pathological functions of IL-22 in disease progression, an in-depth understanding of the interactions of IL-22 with other cytokines like IL-17 and the endogenous neutralizer IL-22BP, and further exploration of the internal mechanisms by which IL-22 protects against NAFLD are warranted.